Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Allarity Therapeutics, Inc. - Common stock (NQ: ALLR ) 0.1829 +0.0062 (+3.51%) Streaming Delayed Price Updated: 3:59 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Allarity Therapeutics, Inc. - Common stock < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket April 11, 2024 Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant... Via Benzinga Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket April 08, 2024 Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares rose sharply during today’s pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of... Via Benzinga Why Reliance Global Group Shares Are Trading Lower By Around 11%; Here Are 20 Stocks Moving Premarket April 05, 2024 Shares of Reliance Global Group, Inc. (NASDAQ: RELI) fell sharply in today’s pre-market trading after reporting financial results for the year ended Dec 31, 2023. Via Benzinga Allarity Therapeutics: Q4 Earnings Insights March 08, 2024 Via Benzinga Allarity Therapeutics Announces 1-for-20 Reverse Stock Split April 04, 2024 From Allarity Therapeutics, Inc. Via GlobeNewswire Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer March 27, 2024 From Allarity Therapeutics, Inc. Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday March 26, 2024 It's time to dive into the biggest pre-market stock movers on Tuesday as we check out all of the hottest news moving shares this morning! Via InvestorPlace Allarity Therapeutics Receives Extension from Nasdaq Hearings Panel to Regain Compliance with Listing Rules 5550(a)(2) and 5550(b)(1) March 25, 2024 From Allarity Therapeutics, Inc. Via GlobeNewswire Allarity Therapeutics Reports Full Year 2023 Financial Results and Provides a Business Update March 08, 2024 From Allarity Therapeutics, Inc. Via GlobeNewswire Allarity Therapeutics to Present at Biomarkers 2024 February 28, 2024 From Allarity Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session December 14, 2023 Via Benzinga Allarity Therapeutics Announces Thomas Jensen as Interim CEO and Appointment of Jeremy R. Graff, PhD as Key Executive Advisor December 12, 2023 From Allarity Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session December 08, 2023 Via Benzinga Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session December 06, 2023 Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session December 06, 2023 Via Benzinga Why SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket December 06, 2023 Shares of SentinelOne, Inc. (NYSE: S) rose sharply in pre-market trading after the company reported stronger-than-expected results for its third quarter and raised its annual revenue outlook. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 06, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session December 05, 2023 Via Benzinga Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session December 05, 2023 Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results. Via Benzinga Dow Falls 100 Points; ISM Services PMI Increases In November December 05, 2023 U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Tuesday. The Dow traded down 0.28% to 36,103.52 while the NASDAQ rose 0.32% to 14,230.64. The S&P... Via Benzinga Topics Stocks Exposures US Equities Wells Fargo Layoffs 2024: What to Know About the Latest WFC Job Cuts December 05, 2023 Wells Fargo layoffs are coming in Q4 as the banking company expects up to pay $1 billion in severance costs during the period. Via InvestorPlace Topics Workforce Exposures Layoff Why Is Allarity Therapeutics (ALLR) Stock Up 42% Today? December 05, 2023 Allarity Therapeutics stock is rising higher on Tuesday with heavy trading of ALLR stock alongside early clinical trial data. Via InvestorPlace US Stocks Down; JM Smucker Posts Upbeat Earnings December 05, 2023 U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.23% to 36,120.88 while the NASDAQ fell... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Tuesday's Pre-Market Session December 05, 2023 Via Benzinga Allarity’s Early Phase 2 Stenoparib Data Indicates Clinical Benefit in Women with Advanced Ovarian Cancer Selected with DRP® Companion Diagnostic December 05, 2023 From Allarity Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session November 20, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session October 27, 2023 Via Benzinga Allarity Therapeutics to Present at Biomarkers Europe 2023 October 02, 2023 From Allarity Therapeutics, Inc. Via GlobeNewswire Allarity Therapeutics Gaining Momentum? Hits Multiple Milestones Including Positive Publications In PLOS One And At ASCO, Positive Early Data From An Ongoing Clinical Trial, And External Partnering For Its DRP(R) Technology September 14, 2023 Via ACCESSWIRE Allarity Therapeutics Gaining Momentum? Hits Multiple Milestones Including Positive Publications In PLOS One And At ASCO, Positive Early Data From An Ongoing Clinical Trial, And External Partnering For Its DRP® Technology September 13, 2023 Allarity Therapeutics (NASDAQ: ALLR) is a biotechnology company focused on realizing true personalized cancer care by developing targeted cancer therapies coupled with companion diagnostics. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.